Republic of the Philippines
Department of Health
OFFICE  OF THE SECRETARY

<date>3/12/1990</date>

<doctype>ADMINISTRATIVE ORDER</doctype>
<docnum>No. 99, s. 1990</docnum>

<subject>SUBJECT : Requirements for Labeling Materials of Categories of Pharmaceutical Products Containing Four or More Active Ingredients outside the Coverage of A.O. 85 s., 1990.</subject>

<body>



Section 1: Applicability of the Provisions of A.O. 55 s., 1990

 All pertinent provisions of A.O. 55 s., 1990 on general and specific requirements for labeling materials of pharmaceutical products shall apply to products containing four or more active ingredients covered by this A.O.


Section Coverage

 All multi-active ingredient pharmaceutical products containing four or more active ingredients not covered by A.O. 85 s., 1990 are covered by this A.O.

Section 3: Generic Labeling

 For these multi-active ingredient products covered by this A.O., the Generic Name for each active ingredient with the corresponding strength or concentration shall be printed within the outline box on the principal display panel with the Trade or Brand Name of the product printed in smaller letters than each generic name immediately below the box as shown in the example below:

<image>table_1.png</image>


<image>table_2.png</image>

Section 4: Procedure for Changing Over to New Labels

	4.1 All drug establishments that own registered drug products covered under this A.O. shall present their proposed generic labels in compliance with the above for review and approval by BFAD not later than March 31, 1991.

	4.2 All satisfactory applications for new generic labels covered by this A.O. submitted within March 31, 1991 deadline shall be approved by BFAD no later than May 31, 1991.

	4.3 Starting sixty (60) days after approval but not later than August 1, 1991, only such approved generic labels shall be used for these products in new production. The drug establishment is required to submit the last batch number bearing the new generic label before the start of actual production with the new label.

	4.4 After October 31, 1991, all covered products with the old label shall be deemed misbranded and subject to seizure by BFAD.

	4.5 It shall be the responsibility of the drug establishment to ascertain the coverage of this A.O. on its products.

	4.6 Remedial generic labeling according to the provisions of A.O. 79 s., 1989 is available to products covered by this A.O.

	4.7 Approval of the new label under this new A.O. should not be taken to mean that the present formula for the FDC is acceptable. This formula will still be subject to review per A.O. 96 s., 1990.

Separability Clause

In case any provision of the A.O. is declared contrary to law or unconstitutional, other provisions which are not affected thereby shall continue to be in force and in effect

Repealing Clause

All A.O.s, Rules and Regulations, and other Administrative Issuance or parts thereof, inconsistent with the provisions of the A.O. are thereby repealed and modified accordingly.

Effectivity

This A.O. shall take effect 15 days after its publication in two newspapers of general circulation.

</body>

<sign>ALFREDO R.A. BENGZON, M.D.</sign>
<signtitle>Secretary of Health</signtitle>